{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:51:06Z","timestamp":1793170266883,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jctube.2024.100439","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T09:18:01Z","timestamp":1713259081000},"page":"100439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Characteristics and outcomes of the duration of treatment with adjunctive corticosteroids in intraocular tuberculosis"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-2949","authenticated-orcid":false,"given":"Yaninsiri","family":"Ngathaweesuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitrapa","family":"Janthayanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7937-7406","authenticated-orcid":false,"given":"Narumon","family":"Keorochana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2024.100439_b0005","unstructured":"World Health Organization, \u2018Global Tuberculosis report 2022\u2019, 2022. [Online]. Available: http:\/\/apps.who.int\/bookorders."},{"key":"10.1016\/j.jctube.2024.100439_b0010","unstructured":"World Health Organization, \u2018Global Tuberculosis report 2021\u2019, 2021. [Online]. Available: http:\/\/apps.who.int\/bookorders."},{"key":"10.1016\/j.jctube.2024.100439_b0015","doi-asserted-by":"crossref","unstructured":"A. Abdisamadov and O. Tursunov, \u2018Ocular tuberculosis epidemiology, clinic features and diagnosis: A brief review\u2019, Tuberculosis, vol. 124. Churchill Livingstone, Sep. 01, 2020. doi: 10.1016\/j.tube.2020.101963.","DOI":"10.1016\/j.tube.2020.101963"},{"key":"10.1016\/j.jctube.2024.100439_b0020","doi-asserted-by":"crossref","unstructured":"S. Sukavatcharin, O. Kijdaoroong, K. Lekhanont, and S. Arj-Ong Vallipakorn, \u2018Pattern of Uveitis in a Tertiary Ophthalmology Center in Thailand\u2019, Ocul Immunol Inflamm, vol. 25, pp. S94\u2013S99, Aug. 2017, doi: 10.1080\/09273948.2016.1215475.","DOI":"10.1080\/09273948.2016.1215475"},{"key":"10.1016\/j.jctube.2024.100439_b0025","doi-asserted-by":"crossref","unstructured":"I. Testi et al., \u2018Ocular tuberculosis: Where are we today?\u2019, Indian Journal of Ophthalmology, vol. 68, no. 9. Wolters Kluwer Medknow Publications, pp. 1808\u20131817, Sep. 01, 2020. doi: 10.4103\/ijo.IJO_1451_20.","DOI":"10.4103\/ijo.IJO_1451_20"},{"issue":"3","key":"10.1016\/j.jctube.2024.100439_b0030","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/09273948.2019.1589527","article-title":"Pattern and outcome of uveitis in a tertiary military hospital in thailand","volume":"28","author":"Keorochana","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"sup1","key":"10.1016\/j.jctube.2024.100439_b0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09273948.2020.1774905","article-title":"Visual morbidity in ocular tuberculosis-collaborative ocular tuberculosis study (COTS)-1: Report #6","volume":"28","author":"Agrawal","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jctube.2024.100439_b0040","doi-asserted-by":"crossref","unstructured":"M. Ang and S. P. Chee, \u2018Controversies in ocular tuberculosis\u2019, British Journal of Ophthalmology, vol. 101, no. 1. BMJ Publishing Group, pp. 6\u20139, Jan. 01, 2017. doi: 10.1136\/bjophthalmol-2016-309531.","DOI":"10.1136\/bjophthalmol-2016-309531"},{"key":"10.1016\/j.jctube.2024.100439_b0045","doi-asserted-by":"crossref","unstructured":"A. Gupta, A. Sharma, R. Bansal, and K. Sharma, \u2018Classification of intraocular tuberculosis\u2019, Ocular Immunology and Inflammation, vol. 23, no. 1. Informa Healthcare, pp. 7\u201313, Feb. 01, 2015. doi: 10.3109\/09273948.2014.967358.","DOI":"10.3109\/09273948.2014.967358"},{"issue":"3","key":"10.1016\/j.jctube.2024.100439_b0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"sup1","key":"10.1016\/j.jctube.2024.100439_b0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/09273948.2019.1653933","article-title":"Standardization of nomenclature for ocular tuberculosis-results of collaborative ocular tuberculosis study (COTS) workshop","volume":"28","author":"Agrawal","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jctube.2024.100439_b0060","doi-asserted-by":"crossref","unstructured":"I. Testi et al. \u2018Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1\u2019, Ocular Immunology and Inflammation vol. 28, no. sup1 2020 Taylor and Francis Ltd. 10.1080\/09273948.2019.1646774 8 16.","DOI":"10.1080\/09273948.2020.1744669"},{"issue":"1","key":"10.1016\/j.jctube.2024.100439_b0065","first-page":"11","article-title":"Treatment outcome in patients with presumed tubercular uveitis at a tertiary referral eye care centre in Singapore","volume":"38","author":"Ang","year":"2018","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jctube.2024.100439_b0070","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.3109\/09273948.2015.1133839","article-title":"Epidemiology of uveitis in a tertiary eye center in myanmar","volume":"25","author":"Win","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"10.1016\/j.jctube.2024.100439_b0075","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","article-title":"Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1","volume":"135","author":"Agrawal","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jctube.2024.100439_b0080","first-page":"628","article-title":"\u2018Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis\u2019, in Survey of Ophthalmology","author":"Kee","year":"2016","journal-title":"Elsevier USA"},{"key":"10.1016\/j.jctube.2024.100439_b0085","doi-asserted-by":"crossref","unstructured":"C. J. Lin et al., \u2018Clinical Manifestations and Outcomes of Tubercular Uveitis in Taiwan\u2014A Ten-Year Multicenter Retrospective Study\u2019, Medicina (Lithuania), vol. 58, no. 3, Mar. 2022, doi: 10.3390\/medicina58030376.","DOI":"10.3390\/medicina58030376"},{"issue":"4","key":"10.1016\/j.jctube.2024.100439_b0090","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ajo.2009.11.020","article-title":"Ocular signs predictive of tubercular uveitis","volume":"149","author":"Gupta","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jctube.2024.100439_b0095","unstructured":"A. Gupta, V. Gupta, S. Arora, M. R. Dogra, and P. Bambery, \u2018PCR-POSITIVE TUBERCULAR RETINAL VASCULITIS Clinical Characteristics and Management\u2019."},{"issue":"4","key":"10.1016\/j.jctube.2024.100439_b0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1076\/ocii.10.4.293.15590","article-title":"Choroidal tubercles in disseminated tuberculosis diagnosed by the polymerase chain reaction of aqueous humor","volume":"10","author":"Biswas","year":"2003","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jctube.2024.100439_b0105","doi-asserted-by":"crossref","unstructured":"Y. Mao, X. Y. Peng, Q. S. You, H. Wang, M. Zhao, and J. B. Jonas, \u2018Tuberculous uveitis in China\u2019, Acta Ophthalmol, vol. 92, no. 5, 2014, doi: 10.1111\/aos.12351.","DOI":"10.1111\/aos.12351"},{"issue":"4","key":"10.1016\/j.jctube.2024.100439_b0110","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijid.2008.09.018","article-title":"Ocular tuberculosis: diagnostic and treatment challenges","volume":"13","author":"Alvarez","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jctube.2024.100439_b0115","author":"Huebner","year":"1993","journal-title":"\u2018The Tuberculin Skin Test\u2019"},{"key":"10.1016\/j.jctube.2024.100439_b0120","doi-asserted-by":"crossref","unstructured":"R. Long, \u2018The Canadian Lung Association\/Canadian Thoracic Society and tuberculosis prevention and control\u2019, 2007.","DOI":"10.1155\/2007\/612974"},{"key":"10.1016\/j.jctube.2024.100439_b0125","series-title":"2020 Morbidity and Mortality Weekly Report Recommendations and Reports Centers for Disease Control and Prevention MMWR Editorial and Production Staff (Serials) MMWR Editorial Board\u2019","article-title":"\u2018Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC","author":"Redfield","year":"2020"},{"issue":"10","key":"10.1016\/j.jctube.2024.100439_b0130","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.rmed.2006.01.014","article-title":"Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis","volume":"100","author":"G\u00fclbay","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jctube.2024.100439_b0135","doi-asserted-by":"crossref","unstructured":"R. Bansal, A. Gupta, V. Gupta, M. R. Dogra, P. Bambery, and S. K. Arora, \u2018Role of Anti-Tubercular Therapy in Uveitis With Latent\/Manifest Tuberculosis\u2019, Am J Ophthalmol, vol. 146, no. 5, 2008, doi: 10.1016\/j.ajo.2008.06.011.","DOI":"10.1016\/j.ajo.2008.06.011"},{"key":"10.1016\/j.jctube.2024.100439_b0140","article-title":"\u2018Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in","author":"Morimura","year":"2002","journal-title":"Japan\u2019"},{"key":"10.1016\/j.jctube.2024.100439_b0145","doi-asserted-by":"crossref","unstructured":"F. I. Shakarchi, \u2018Ocular tuberculosis: Current perspectives\u2019, Clinical Ophthalmology, vol. 9. Dove Medical Press Ltd, pp. 2223\u20132227, Nov. 26, 2015. doi: 10.2147\/OPTH.S65254.","DOI":"10.2147\/OPTH.S65254"},{"issue":"1","key":"10.1016\/j.jctube.2024.100439_b0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/09273948.2014.926936","article-title":"Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists","volume":"23","author":"Lou","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.jctube.2024.100439_b0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/09273948.2014.986584","article-title":"The role of anti-tubercular therapy in patients with presumed ocular tuberculosis","volume":"23","author":"Agrawal","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.jctube.2024.100439_b0160","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjophthalmol-2011-300209","article-title":"Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: A case-control study","volume":"96","author":"Ang","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jctube.2024.100439_b0165","doi-asserted-by":"crossref","unstructured":"Y. Fern\u00e1ndez Zamora, L. Peixoto Finamor, L. M. P Silva, D. S. Rodrigues, R. P. Casaroli-Marano, and C. Muccioli, \u2018Clinical features and management of presumed ocular tuberculosis: A long-term follow-up cohort study in a tertiary referral center in Brazil\u2019, Eur J Ophthalmol, vol. 32, no. 4, pp. 2181\u20132188, Jul. 2022, doi: 10.1177\/11206721211044624.","DOI":"10.1177\/11206721211044624"},{"issue":"2","key":"10.1016\/j.jctube.2024.100439_b0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ophtha.2020.01.008","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579424000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579424000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:20:44Z","timestamp":1738729244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579424000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":34,"alternative-id":["S2405579424000263"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2024.100439","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and outcomes of the duration of treatment with adjunctive corticosteroids in intraocular tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2024.100439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100439"}}